Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to evaluate the effectiveness of "RehaCom," a computerized treatment for memory deficits, in a 16-session, interactive course. Following a manualized approach, the Rehacom modules will be used for the repeated application of the content acquired during 1-on-1 memory strategy training. The goal is to improve face/name, list and verbal memory of patients who survived a moderate to severe traumatic brain injury.


Clinical Trial Description

This randomized clinical trial (RCT) consists of 20 chronic moderate-to-severe TBI patients who will receive memory strategy training and complete three memory modules of the RehaCom at one of the Kessler Foundation locations. Changes in attention, processing speed, verbal/non-verbal new learning and memory (NLM) and executive control will be assessed via pre/post and 3-month follow-up assessments before and after the 8-10 week intervention. Self-report questionnaires will also track functional and emotional outcomes such as mood and anxiety, cognition, quality of life, self-efficacy, deficit awareness, community participation, and readiness for occupational functioning ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04239456
Study type Interventional
Source Kessler Foundation
Contact
Status Active, not recruiting
Phase N/A
Start date December 1, 2018
Completion date November 28, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06163833 - Mesenchymal Stromal Cells for Traumatic Brain Injury Phase 2
Completed NCT02858544 - Concussion in Motor Vehicle Accidents: The Concussion Identification Index N/A
Recruiting NCT05636020 - Intervention to Change Affect Recognition and Empathy N/A
Completed NCT04315389 - SG Healthcare and Assistive Robotics Programme (SHARP) - Proof of Concept Study
Completed NCT05521815 - Effect of Early Coma Arousal Therapy on Conscious Level Recovery and Cognition in Traumatic Brain Injury N/A